Suppr超能文献

血清皮质醇水平与新诊断的重度抑郁症患者严重程度及改善的关联:来自埃塞俄比亚西南部吉玛医疗中心的研究

Association of serum cortisol level with severity of depression and improvement in newly diagnosed patients with major depressive disorder in Jimma medical center, Southwest Ethiopia.

机构信息

Department of Psychiatry, Jimma University, Institute of Health, Faculty of Medical Science, Jimma, Ethiopia.

Department of Biomedical Sciences, Jimma University, Institute of Health, Faculty of Medical Science, Jimma, Ethiopia.

出版信息

PLoS One. 2020 Oct 16;15(10):e0240668. doi: 10.1371/journal.pone.0240668. eCollection 2020.

Abstract

BACKGROUND

Major Depressive Disorder (MDD) is the leading psychiatric disorder in low- and middle-income countries, and is to be the second leading cause of burden of disease by 2020. Cortisol plays a significant role in pathophysiology of MDD. Depression can alter serum cortisol level. However, the change in serum cortisol level and its association with depressive symptom severity and improvement among patients with MDD is not well studied.

OBJECTIVE

To outline change in serum cortisol levels and its association with severity and improvement of depressive symptoms in newly diagnosed patients with MDD.

METHOD

Hospital based longitudinal study was conducted among 34 newly diagnosed patients who met DSM-V criteria of MDD. Venous blood sample was performed twice; pre- and post- 8 weeks of treatment. Serum cortisol concentration was measured using an extracted radioimmunoassay. The 17-item Hamilton Depression Scale (HAM-D) was used to rate depression at baseline and after 8 weeks of treatment. Paired t-test was done to look the mean difference of serum cortisol level and HAM-D, before and after treatment. Pearson correlation was done to look the association between serum cortisol levels, HAM-D scores and, sociodemographic and clinical factors. Statistical significance was set at p<0.05.

RESULTS

There is no significant difference in cortisol concentrations at baseline and end line (t (33) = 2.02, p = 0.052). However, there is significant difference in HAM-D total score (t (33) = 5.67, p<0.001). Baseline and end line serum cortisol levels were significantly correlated (r = .561, p = .001). Monthly family income is correlated with baseline HAM-D total score (r = -0.373, p = .030). There is no significant relationship between baseline serum cortisol level and HAM-D score. There is also no significant relationship between end line serum cortisol level and HAM-D score.

CONCLUSIONS

The symptoms of MDD were reduced following treatment but there is no significant difference in serum cortisol levels. Baseline and end line serum cortisol levels were significantly correlated. We recommend further research based on large sample.

摘要

背景

重度抑郁症(MDD)是中低收入国家的主要精神疾病,到 2020 年,它将成为第二大疾病负担原因。皮质醇在 MDD 的病理生理学中起重要作用。抑郁会改变血清皮质醇水平。然而,MDD 患者的血清皮质醇水平变化及其与抑郁症状严重程度和改善的关系尚未得到很好的研究。

目的

概述新诊断为 MDD 的患者血清皮质醇水平的变化及其与抑郁症状严重程度和改善的关系。

方法

对 34 名符合 DSM-V 重度抑郁症标准的新诊断患者进行了基于医院的纵向研究。进行了两次静脉血样采集;治疗前和治疗后 8 周。使用提取放射免疫分析法测量血清皮质醇浓度。使用 17 项汉密尔顿抑郁量表(HAM-D)在基线和 8 周治疗后评估抑郁。采用配对 t 检验比较治疗前后血清皮质醇水平和 HAM-D 的平均值差异。采用 Pearson 相关分析评估血清皮质醇水平、HAM-D 评分与社会人口学和临床因素之间的关系。统计学意义设定为 p<0.05。

结果

基线和终点的皮质醇浓度无显著差异(t (33) = 2.02,p = 0.052)。然而,HAM-D 总分有显著差异(t (33) = 5.67,p<0.001)。基线和终点的血清皮质醇水平显著相关(r =.561,p =.001)。月家庭收入与基线 HAM-D 总分相关(r = -0.373,p =.030)。基线血清皮质醇水平与 HAM-D 评分无显著关系。终点血清皮质醇水平与 HAM-D 评分也无显著关系。

结论

MDD 症状在治疗后减轻,但血清皮质醇水平无显著差异。基线和终点的血清皮质醇水平显著相关。我们建议进行基于大样本的进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef46/7567351/442be007e0f4/pone.0240668.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验